Global Dapagliflozin Market 2024-2030

    In Stock




    Dapagliflozin prevents blood sugar absorption by working in the kidneys. This lowers the level of blood sugar. Metformin decreases the release of stored sugar from the liver, decreases the absorption of sugar from the stomach, and improves how well your body uses sugar.


    The principal use of Dapagliflozin Heart failure can also be treated with it. If you are unable to take metformin and have type 2 diabetes, dapagliflozin is typically given.


    Dapagliflozin lessens the amount of effort your heart must exert to pump blood throughout your body if you have heart failure. Breathlessness, exhaustion, and swelling in your lower legs are some of the symptoms of heart failure that are alleviated by doing this. Additionally, it lessens the possibility of your heart being weaker.


    taking dapagliflozin tablets without first consulting your doctor. If you stop taking it suddenly, your diabetes or heart failure may get worse. Speak to your doctor if this medication isn’t doing the job for you or if any side effects are bothering you.


     Two medications have been licenced for the treatment of diabetes: metformin and dapagliflozin. Some studies have suggested that metformin may cause weight loss in addition to its effects on glucose. In diabetic patients on dapagliflozin therapy, there is a small but long-lasting weight loss.




    infogrpahic : Dapagliflozin Market , Dapagliflozin Market Size, Dapagliflozin Market Trends, Dapagliflozin Market Forecast, Dapagliflozin Market Risks, Dapagliflozin Market Report, Dapagliflozin Market Share


    The Global DAPAGLIFLOZIN market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.



    To expand patient access, New Delhi-based pharmaceutical company Zydus Healthcare said that it has introduced generic anti-diabetic Dapagliflozin pills across the nation under the brand name “Dapaglyn” at a very reasonable price.


    Following the product’s patent expiration, the business released its Dapagliflozin tablets in India in two strengths: 10 mg and 5 mg, priced at respectively.


    the pharmaceutical company Zydus Healthcare said that it has expanded patient access by introducing generic anti-diabetic Dapagliflozin pills across the nation under the brand name “Dapaglyn” at a very reasonable price.


    The drug will be extremely cost-effective, with a price that is 1/3 less than that of the Dapagliflozin brands already offered in India, in keeping with its aim to make therapies available and cheap to patients, it continued. According to Zydus Healthcare, the once-daily tablets are recommended as a supplement to a healthy diet and regular exercise to help persons with Type 2 diabetes mellitus better regulate their blood sugar levels.





    • Morepen Laboratories Ltd.
    • Solfyn International LLP.
    • SENOVA Technology Co., Ltd.
    • Shandong Octagon Chemicals Limited.
    • Apino Pharma Co., Ltd.




    1. How many DAPAGLIFLOZIN are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global DAPAGLIFLOZIN and key vendor selection criteria
    3. Where is the DAPAGLIFLOZIN manufactured? What is the average margin per unit?
    4. Market share of Global DAPAGLIFLOZIN market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global DAPAGLIFLOZIN in-house
    6. key predictions for next 5 years in Global DAPAGLIFLOZIN market
    7. Average B-2-B DAPAGLIFLOZIN market price in all segments
    8. Latest trends in DAPAGLIFLOZIN market, by every market segment
    9. The market size (both volume and value) of the DAPAGLIFLOZIN market in 2024-2030 and every year in between?
    10. Production breakup of DAPAGLIFLOZIN market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2024-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2024-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop